Welcome to LookChem.com Sign In|Join Free
  • or
Z-ASP-OME is a chemical compound that integrates the amino acid aspartic acid (ASP) and is specifically engineered for cancer treatment. It functions as a proenzyme, capable of selectively targeting and inhibiting the overactive cell-death protein caspase-3, which is commonly found in cancerous cells. This distinctive mechanism of action positions Z-ASP-OME as a potential candidate for targeted cancer therapy, offering the possibility of inducing apoptosis in cancer cells while preserving healthy cells. Its chemical structure also facilitates efficient delivery to tumor sites, enhancing its therapeutic impact and minimizing adverse side effects. Z-ASP-OME is thus an innovative development in oncology, with the potential to markedly improve patient outcomes for specific cancer types.

4668-42-2

Post Buying Request

4668-42-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

4668-42-2 Usage

Uses

Used in Oncology:
Z-ASP-OME is used as a targeted cancer therapy agent for its ability to selectively inhibit the overactive caspase-3 protein in cancer cells. This selective action is crucial for inducing apoptosis in cancer cells while leaving healthy cells unharmed, thereby reducing the risk of damage to normal tissues during treatment.
Used in Drug Delivery Systems:
The chemical structure of Z-ASP-OME allows for efficient delivery to tumor sites, which is essential for enhancing the effectiveness of cancer treatment. This targeted delivery system can potentially increase the therapeutic index of the compound, ensuring that a higher concentration reaches the tumor while minimizing exposure to healthy tissues, thus reducing the likelihood of side effects.
Used in Cancer Research:
Z-ASP-OME's unique mechanism of action also makes it a valuable tool in cancer research. It can be utilized to study the role of caspase-3 in cancer cell survival and to explore new avenues for developing targeted therapies that exploit the vulnerabilities of cancer cells.
Used in Combination Therapies:
Given its selective targeting of caspase-3, Z-ASP-OME may also be used in combination with other cancer treatments, such as chemotherapy or radiation therapy, to enhance their effectiveness. This synergistic approach could potentially overcome resistance mechanisms in cancer cells and improve overall treatment outcomes for patients.

Check Digit Verification of cas no

The CAS Registry Mumber 4668-42-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,6,6 and 8 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 4668-42:
(6*4)+(5*6)+(4*6)+(3*8)+(2*4)+(1*2)=112
112 % 10 = 2
So 4668-42-2 is a valid CAS Registry Number.
InChI:InChI=1/C13H15NO6/c1-19-12(17)10(7-11(15)16)14-13(18)20-8-9-5-3-2-4-6-9/h2-6,10H,7-8H2,1H3,(H,14,18)(H,15,16)/t10-/m0/s1

4668-42-2 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (M2707)  1-Methyl N-Carbobenzoxy-L-aspartate  >98.0%(HPLC)(T)

  • 4668-42-2

  • 5g

  • 490.00CNY

  • Detail
  • TCI America

  • (M2707)  1-Methyl N-Carbobenzoxy-L-aspartate  >98.0%(HPLC)(T)

  • 4668-42-2

  • 25g

  • 1,590.00CNY

  • Detail
  • Alfa Aesar

  • (H59571)  N-Benzyloxycarbonyl-L-aspartic acid 1-methyl ester, 98%   

  • 4668-42-2

  • 1g

  • 452.0CNY

  • Detail
  • Alfa Aesar

  • (H59571)  N-Benzyloxycarbonyl-L-aspartic acid 1-methyl ester, 98%   

  • 4668-42-2

  • 5g

  • 1211.0CNY

  • Detail
  • Aldrich

  • (95998)  Z-Asp-OMe  ≥98.0% (TLC)

  • 4668-42-2

  • 95998-5G

  • 2,639.52CNY

  • Detail

4668-42-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name (3S)-4-methoxy-4-oxo-3-(phenylmethoxycarbonylamino)butanoic acid

1.2 Other means of identification

Product number -
Other names Z-Asp-Ome

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:4668-42-2 SDS

4668-42-2Relevant academic research and scientific papers

Total Synthesis of cis-Clavicipitic Acid from Asparagine via Ir-Catalyzed C-H bond Activation as a Key Step

Tahara, Yu-Ki,Ito, Mamoru,Kanyiva, Kyalo Stephen,Shibata, Takanori

, p. 11340 - 11343 (2015/08/03)

4-Substituted tryptophan derivatives and the total synthesis of cis-clavicipitic acid were achieved in reactions in which Ir-catalyzed C-H bond activation was a key step. The starting material for these reactions is asparagine, which is a cheap natural amino acid. The reductive amination step from the 4-substituted tryptophan derivative gave cis-clavicipitic acid with perfect diastereoselectivity.

A direct route to 2,2,5-trisubstituted pyrrolidines of relevance to kaitocephalin

Chandan, Nandkishkor,Moloney, Mark G.

supporting information, p. 1987 - 1990 (2013/04/10)

2,2,5-Trisubstituted pyrrolidines of relevance to the core of kaitocephalin are readily available by an oxime ring closure using substrates derived from aspartic acid.

An access to aza-Freidinger lactams and E-locked analogs

Ottersbach, Philipp A.,Schmitz, Janina,Schnakenburg, Gregor,Gütschow, Michael

, p. 448 - 451 (2013/04/11)

Freidinger lactams, possessing a peptide bond configuration locked to Z, are important key elements of conformationally restricted peptidomimetics. In the present work, the CαHi+1 unit has been replaced by N, leading to novel aza-Fre

A PREPARATION METHOD OF SITAGLIPTIN

-

, (2012/11/13)

The present invention relates to a preparation method of sitagliptin, and more particularly, to a method of preparing sitagliptin using L-aspartic acid having a (R)-beta amino acid structure by mild amide formation, by the use of industrially applicable halo isopropylmagnesium, and by removal of amine protecting group using Pd/C and H2 and carbonyl reduction using reducing agent.

A versatile and selective chemo-enzymatic synthesis of β-protected aspartic and γ-protected glutamic acid derivatives

Nuijens, Timo,Kruijtzer, John A.W.,Cusan, Claudia,Rijkers, Dirk T.S.,Liskamp, Rob M.J.,Quaedflieg, Peter J.L.M.

experimental part, p. 2719 - 2721 (2009/09/06)

Two versatile, high yielding, and efficient chemo-enzymatic methods for the synthesis of β-protected Asp and γ-protected Glu derivatives using Alcalase are described. The first method is based on the α-selective enzymatic hydrolysis of symmetrical aspartyl and glutamyl diesters. The second method involving mixed diesters comprises a three-step protocol using (i) α-selective enzymatic methyl-esterification, (ii) chemical β-esterification, and finally (iii) α-selective enzymatic methyl ester hydrolysis. The yields of the purified β- and γ-esters range from 77% to 91%.

Utility of tetrathiomolybdate and tetraselenotungstate: Efficient synthesis of cystine, selenocystine, and their higher homologues

Bhat, Ramakrishna G.,Porhiel, Emmanuel,Saravanan, Vadivelu,Chandrasekaran, Srinivasan

, p. 5251 - 5253 (2007/10/03)

Efficient synthesis of cystine, selenocystine, and their higher homologues like homo and bishomo amino acid derivatives from natural amino acid derivatives using tetrathiomolybdate and tetraselenotungstate reagents under mild and neutral conditions is reported. The generality of the reaction has been studied by capping various groups to amino and carboxyl components of canonical amino acids.

The Preference Profile in Ruthenium Tetroxide Oxidations

Ranganathan,Muraleedharan,Bhattacharyya,Kundu

, p. 583 - 589 (2007/10/03)

The preference profile of RuVIII-generated in a catalytic cycle, maintained by periodate in carbon tetrachloride : acetonitrile : water -has been examined from a practical vantage using tyrosine, phenylalanine and lysine as primary substrates. Other factors such as pH, acetonitrile versatility, transport of oxidized ruthenium species across the layers and hydrophobic alignment, influence the course of the reaction. Aryl oxidation, which takes place at the organic interface, is strongly influenced by ring perturbation (pOH-C6H4CH2CH,++; PhCH2CH,+, PhCH2O,+; PhCH2OCONH(Z),-; PhCH2OCO,-; pOH-C6H4CH2CO,+; PhCH2CO,-; PhCO,-). In the case of tyrosine, the preference profile switches from ring oxidation at pH 3 to α-amino group oxidation at pH 6 and 9, whilst with phenylalanine, the amino group is exclusively oxidized even at pH 3. With lysine, the reasonable differences in pKa between the α-amino group (8.95) and the ω-amino unit (10.53), elicit sharp preferences. At pH 3 as well as at 6, the α-amino group is selectively oxidized leading to glutaric acid mono-amide, a finding supported by studies with Nα and Nω protected lysines. Lysine and arginine side-chains are found largely unaffected by the reagent at pH 3 and 6. The findings have been rationalized on the basis of an integrated mechanism. The work has endeavoured to reconcile seemingly conflicting reports in the literature and to project the reagent for selective modifications in synthesis.

Synthesis of (3R)- and (3S)-3,4-diamino-butyric acid from L-aspartic acid

Misiti,Santaniello,Zappia

, p. 883 - 891 (2007/10/02)

A short and convenient synthesis for both enantiomers of GABOB amino-analogue 1a,b is reported, starting from L-aspartic acid. The protected diester 3 is the common intermediate for the synthetic pathway.

The transformation of histidine side chain to non-coded asparagines

Ranganathan, Subramania,Ranganathan, Darshan,Bhattacharyya, Dipti

, p. 5615 - 5618 (2007/10/02)

The transformation of the histidine side chain to that of Nω-carbamoyl asparagine, Nω-formyl asparagine, Nω-benzoyl asparagine, β-cyano alanine and aspartic acid has been described, involving as the primary step, the Ru(VI

MONO-ESTERIFICATION OF N-PROTECTED DI-ACIDS ASPARTIC AND GLUTAMIC BY CHLOROFORMATE ACTIVATION

Jouin, P.,Castro, B.,Zeggaf, C.,Pantaloni, A.,Senet, J.P,et al

, p. 1665 - 1668 (2007/10/02)

Mono-esters of N-protected di-acids aspartic and glutamic are prepared by a one-pot activation with alkyl chloroformates or isopropenyl chloroformate and an additionnal alcohol.This process involves the intermediate internal anhydride formation.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 4668-42-2